Chirantan Bose, Vidya H. Veldore, Anjali Kulkarni, Giridharan Periyasamy et al.
e23422 Background: FGFR alterations are established actionable drivers in solid tumors, with particular clinical relevance in hepatobiliary malignancies. The advent of selective and next-generation FGFR inhibitors has expanded therapeutic options; however, durable responses remain inconsistent. Emer...
Rajiv Kumar, Vijay Patil, Yasmin Abdul Rashid, Alfredo Addeo et al.
ABSTRACT The Excellence in Oncology Care (EIOC) 2023 Congress, held in Dubai as a hybrid event, brought together oncologists from the Middle East and the Indian subcontinent. Two panels, comprising 33 experts, developed the first region-specific consensus guidelines to address critical issues in non...